Radiogenomics offers a promising non-invasive approach for characterizing breast cancer (BC), yet its progress is often limited by the scarcity of cohorts containing matched imaging and multi-omics data. Recent advances in generative AI have enabled ...
Respiratory syncytial virus (RSV) remains the leading cause of severe respiratory infections in infants, the elderly, and the immunocompromised. Although stabilized full-length pre-fusion (pre-F) protein vaccines are promising, enhanced respiratory d...
Spatial and activity-dependent gene regulation in the mammalian brain requires coordinated control of RNA synthesis and degradation, yet spatially resolved measurement of RNA turnover kinetics in complex tissues remains technically challenging. Here,...
Genomic foundation models aim to learn general-purpose representations directly from DNA sequence, enabling sequence understanding, generation, and probabilistic reasoning across a wide range of biological tasks. Scaling such models to genomic length...
Deep learning models enable the prediction of clinical endpoints from whole-slide images (WSIs), but many such models function as "black boxes", lacking transparency about whether and which histomorphological patterns drive their predictions, hinderi...
Integrating coding and regulatory variation into unified, interpretable representations remains a challenge in functional genomics. Current approaches either focus on common variants or analyze individual variants in isolation, missing the cumulative...
Bulk OMICs data, such as RNA-seq and proteomics, remain foundational in biomedical and cancer research. While single-cell transcriptomics has revolutionized our understanding of cellular heterogeneity, bulk OMICs continue to provide unique advantages...
The Committee on Publication Ethics (COPE) recommends that publishers do not charge for corrections to published papers. Until late 2024 the Journal of Cancer levied a charge on authors (50% of the original article processing charge, APC) for publica...
Mammalian cell lines are the preferred hosts for producing commercially relevant therapeutic proteins such as antibodies, multispecifics, and cytokine fusion proteins. Even though significant investment is made to optimize upstream and downstream pro...
Join thousands of healthcare professionals staying informed about the latest AI breakthroughs in medicine. Get curated insights delivered to your inbox.